Breaking News Instant updates and real-time market news.

APO

Apollo Global

$53.04 /

+0.17 (+0.32%)

, ATH

Athene Holding

$32.13 /

-0.96 (-2.90%)

06:49
06/18/20
06/18
06:49
06/18/20
06:49

Apollo Global expanding insurance asset management business

Apollo Global (APO) is expanding its insurance asset management business, as Athene Holding (ATH) has entered into a fixed annuity block reinsurance transaction with Jackson National Life Insurance, a subsidiary of Prudential (PRU), with the support of Athene Co-Invest Reinsurance Affiliate. Athene will reinsure a $27B in-force block of fixed deferred and fixed indexed annuities. Athene will also make a $500M equity investment in Jackson, representing an 11% stake in the company. Apollo's insurance platform is anchored by permanent capital vehicle assets from Athene and other insurance platforms. Through Q1 and pro forma for Athene's transaction with Jackson, additional transactions and internal growth, Apollo has added nearly $80B in insurance-related assets under management. Apollo expects this transaction will be immediately accretive; however, the full financial effect is expected to be achieved on a run rate basis in the second half of 2021.

APO

Apollo Global

$53.04 /

+0.17 (+0.32%)

ATH

Athene Holding

$32.13 /

-0.96 (-2.90%)

PRU

Prudential

$63.87 /

-1.9 (-2.89%)

  • 05

    Aug

APO Apollo Global
$53.04 /

+0.17 (+0.32%)

06/08/20 Citi
Citi downgrades Alternative Asset Managers to Market Weight, lowers four ratings
06/08/20 Citi
Apollo Global downgraded to Neutral from Buy at Citi
05/14/20 BMO Capital
Apollo Global downgraded to Market Perform on valuation at BMO Capital
05/14/20 BMO Capital
Apollo Global downgraded to Market Perform from Outperform at BMO Capital
ATH Athene Holding
$32.13 /

-0.96 (-2.90%)

05/12/20 SunTrust
Athene Holding price target lowered to $45 from $61 at SunTrust
04/27/20 Credit Suisse
Athene Holding price target lowered to $46 from $59 at Credit Suisse
03/20/20 RBC Capital
RBC Capital sees some time before Life Insurance returns to 'normal'
03/20/20 RBC Capital
Athene Holding downgraded to Sector Perform from Outperform at RBC Capital
PRU Prudential
$63.87 /

-1.9 (-2.89%)

05/06/20 Piper Sandler
Prudential downgraded to Neutral at Piper Sandler following Q1 results
05/06/20 Piper Sandler
Prudential downgraded to Neutral from Overweight at Piper Sandler
03/20/20 RBC Capital
Prudential downgraded to Sector Perform from Outperform at RBC Capital

TODAY'S FREE FLY STORIES

Periodicals
U.S. official says COVID-19 vaccine output to start by end of summer, CNBC says » 19:22
07/13/20
07/13
19:22
07/13/20
19:22
BNTX

BioNTech

$77.73 /

+7.315 (+10.39%)

, PFE

Pfizer

$35.22 /

+1.38 (+4.08%)

, INO

Inovio

$25.57 /

+2.21 (+9.46%)

, JNJ

Johnson & Johnson

$145.30 /

+2.85 (+2.00%)

, MRNA

Moderna

$71.72 /

+9.15 (+14.62%)

, SPY

SPDR S&P 500 ETF Trust

$314.80 /

-2.81 (-0.88%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

, NVAX

Novavax

$104.46 /

+10.1 (+10.70%)

, MRK

Merck

$77.38 /

+0.64 (+0.83%)

, SNY

Sanofi

$50.96 /

+0.64 (+1.27%)

, GSK

GlaxoSmithKline

$40.07 /

+0.16 (+0.40%)

A senior Trump…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BNTX BioNTech
$77.73 /

+7.315 (+10.39%)

PFE Pfizer
$35.22 /

+1.38 (+4.08%)

INO Inovio
$25.57 /

+2.21 (+9.46%)

JNJ Johnson & Johnson
$145.30 /

+2.85 (+2.00%)

MRNA Moderna
$71.72 /

+9.15 (+14.62%)

SPY SPDR S&P 500 ETF Trust
$314.80 /

-2.81 (-0.88%)

SPX S&P 500
$0.00 /

+ (+0.00%)

NVAX Novavax
$104.46 /

+10.1 (+10.70%)

MRK Merck
$77.38 /

+0.64 (+0.83%)

SNY Sanofi
$50.96 /

+0.64 (+1.27%)

GSK GlaxoSmithKline
$40.07 /

+0.16 (+0.40%)

BNTX BioNTech
$77.73 /

+7.315 (+10.39%)

09:45 Today Canaccord
BioNTech price target raised to $75 from $60 at Canaccord
07/02/20 B. Riley FBR
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR
07/02/20 BMO Capital
Moderna mRNA platform supported by Pfizer vaccine data, says BMO Capital
07/02/20 SVB Leerink
BioNTech price target raised to $42 from $37 at SVB Leerink
PFE Pfizer
$35.22 /

+1.38 (+4.08%)

09:45 Today Canaccord
BioNTech price target raised to $75 from $60 at Canaccord
07/08/20 Piper Sandler
Opko Health price target raised to $6 from $4 at Piper Sandler
07/08/20 Argus
Pfizer positioned for stronger revenue growth in 2021 and beyond, says Argus
07/07/20 Needham
Vaxcyte initiated with a Buy at Needham
INO Inovio
$25.57 /

+2.21 (+9.46%)

07/01/20
Fly Intel: Top five analyst downgrades
07/01/20 Maxim
Inovio downgraded to Hold from Buy at Maxim
07/01/20 Roth Capital
Roth 'unimpressed' with Inovio data, downgrades to Sell with $11 target
07/01/20 Maxim
Inovio downgraded to Hold from Buy at Maxim
JNJ Johnson & Johnson
$145.30 /

+2.85 (+2.00%)

16:13 Today Oppenheimer
Relmada Therapeutics initiated with an Outperform at Oppenheimer
08:42 Today H.C. Wainwright
Pacira price target raised to $68 from $63 at H.C. Wainwright
07/10/20 Jefferies
Pacira price target raised to $69 from $53 at Jefferies
07/06/20 Baird
Cooper Companies downgraded to Neutral, Baird see confluence of issues
MRNA Moderna
$71.72 /

+9.15 (+14.62%)

07:58 Today Brookline
Moderna initiated with a Buy at Brookline
06:10 Today Jefferies
Jefferies starts Moderna with Buy rating, $90 price target
07/08/20 Piper Sandler
Piper reiterates $100 target on Moderna after Phase II study enrolled
07/02/20 BMO Capital
Moderna mRNA platform supported by Pfizer vaccine data, says BMO Capital
SPY SPDR S&P 500 ETF Trust
$314.80 /

-2.81 (-0.88%)

06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
SPX S&P 500
$0.00 /

+ (+0.00%)

06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
NVAX Novavax
$104.46 /

+10.1 (+10.70%)

07/08/20
Fly Intel: Top five analyst downgrades
07/08/20 Ladenburg
Novavax downgraded to Neutral from Buy at Ladenburg
07/07/20 Cantor Fitzgerald
Novavax price target raised to $148 from $88 at Cantor Fitzgerald
07/02/20 B. Riley FBR
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR
MRK Merck
$77.38 /

+0.64 (+0.83%)

06/30/20 SVB Leerink
Seattle Genetics price target raised to $167 from $155 at SVB Leerink
06/30/20 Oppenheimer
Seattle Genetics price target raised to $210 from $200 at Oppenheimer
06/25/20 Lake Street
Lake Street says Keytruda approval improves outlook for Checkpoint's cosibelimab
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
SNY Sanofi
$50.96 /

+0.64 (+1.27%)

07/08/20 Piper Sandler
Piper upgrades Kiadis on 'platform validating' Sanofi deal
07/06/20 Citi
BioMarin price target raised to $148 from $105 at Citi
07/01/20 Roth Capital
Applied Genetic may attract Sanofi takeover interest, says Roth Capital
06/26/20 SunTrust
Translate Bio initiated with a Buy at SunTrust
GSK GlaxoSmithKline
$40.07 /

+0.16 (+0.40%)

12:02 Today UBS
UBS reiterates Buy on GSK as FDA belantamab docs are out
09:13 Today JPMorgan
Ideaya upgraded to Overweight on recent pullback at JPMorgan
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
06/19/20 Barclays
Glaxo belantamab AdCom a surprise, supports cautious view, says Barclays
BNTX BioNTech
$77.73 /

+7.315 (+10.39%)

PFE Pfizer
$35.22 /

+1.38 (+4.08%)

INO Inovio
$25.57 /

+2.21 (+9.46%)

JNJ Johnson & Johnson
$145.30 /

+2.85 (+2.00%)

MRNA Moderna
$71.72 /

+9.15 (+14.62%)

SPY SPDR S&P 500 ETF Trust
$314.80 /

-2.81 (-0.88%)

SPX S&P 500
$0.00 /

+ (+0.00%)

NVAX Novavax
$104.46 /

+10.1 (+10.70%)

MRK Merck
$77.38 /

+0.64 (+0.83%)

SNY Sanofi
$50.96 /

+0.64 (+1.27%)

GSK GlaxoSmithKline
$40.07 /

+0.16 (+0.40%)

  • 19
    May
  • 12
    Feb
  • 06
    Feb
  • 10
    Oct
BNTX BioNTech
$77.73 /

+7.315 (+10.39%)

PFE Pfizer
$35.22 /

+1.38 (+4.08%)

INO Inovio
$25.57 /

+2.21 (+9.46%)

JNJ Johnson & Johnson
$145.30 /

+2.85 (+2.00%)

MRNA Moderna
$71.72 /

+9.15 (+14.62%)

SPY SPDR S&P 500 ETF Trust
$314.80 /

-2.81 (-0.88%)

SPX S&P 500
$0.00 /

+ (+0.00%)

NVAX Novavax
$104.46 /

+10.1 (+10.70%)

MRK Merck
$77.38 /

+0.64 (+0.83%)

SNY Sanofi
$50.96 /

+0.64 (+1.27%)

GSK GlaxoSmithKline
$40.07 /

+0.16 (+0.40%)

BNTX BioNTech
$77.73 /

+7.315 (+10.39%)

PFE Pfizer
$35.22 /

+1.38 (+4.08%)

INO Inovio
$25.57 /

+2.21 (+9.46%)

JNJ Johnson & Johnson
$145.30 /

+2.85 (+2.00%)

MRNA Moderna
$71.72 /

+9.15 (+14.62%)

NVAX Novavax
$104.46 /

+10.1 (+10.70%)

MRK Merck
$77.38 /

+0.64 (+0.83%)

SNY Sanofi
$50.96 /

+0.64 (+1.27%)

GSK GlaxoSmithKline
$40.07 /

+0.16 (+0.40%)

BNTX BioNTech
$77.73 /

+7.315 (+10.39%)

PFE Pfizer
$35.22 /

+1.38 (+4.08%)

INO Inovio
$25.57 /

+2.21 (+9.46%)

JNJ Johnson & Johnson
$145.30 /

+2.85 (+2.00%)

MRNA Moderna
$71.72 /

+9.15 (+14.62%)

SPY SPDR S&P 500 ETF Trust
$314.80 /

-2.81 (-0.88%)

SPX S&P 500
$0.00 /

+ (+0.00%)

NVAX Novavax
$104.46 /

+10.1 (+10.70%)

MRK Merck
$77.38 /

+0.64 (+0.83%)

SNY Sanofi
$50.96 /

+0.64 (+1.27%)

GSK GlaxoSmithKline
$40.07 /

+0.16 (+0.40%)

SPY SPDR S&P 500 ETF Trust
$314.80 /

-2.81 (-0.88%)

SPX S&P 500
$0.00 /

+ (+0.00%)

On The Fly
Fly Intel: After-Hours Movers » 18:58
07/13/20
07/13
18:58
07/13/20
18:58
INMB

INmune Bio

$8.74 /

+1.72 (+24.50%)

, VNDA

Vanda Pharmaceuticals

$11.37 /

-0.125 (-1.09%)

, FREQ

Frequency Therapeutics

$20.43 /

-2.4 (-10.51%)

, EW

Edwards Lifesciences

$67.18 /

-0.67 (-0.99%)

, BA

Boeing

$175.62 /

-2.825 (-1.58%)

, OSMT

Osmotica Pharmaceuticals

$7.71 /

-1.06 (-12.09%)

, ALT

Altimmune

$24.88 /

+2.56 (+11.47%)

Check out this evening's…

Open Full Text

ShowHide Related Items >><<
INMB INmune Bio
$8.74 /

+1.72 (+24.50%)

VNDA Vanda Pharmaceuticals
$11.37 /

-0.125 (-1.09%)

FREQ Frequency Therapeutics
$20.43 /

-2.4 (-10.51%)

EW Edwards Lifesciences
$67.18 /

-0.67 (-0.99%)

BA Boeing
$175.62 /

-2.825 (-1.58%)

OSMT Osmotica Pharmaceuticals
$7.71 /

-1.06 (-12.09%)

ALT Altimmune
$24.88 /

+2.56 (+11.47%)

INMB INmune Bio
$8.74 /

+1.72 (+24.50%)

03/12/20 H.C. Wainwright
INmune Bio price target lowered to $8 from $11 at H.C. Wainwright
03/11/20 Roth Capital
INmune makes progress in all programs, novel COVID-19 approach,says Roth Capital
12/18/19 Roth Capital
INmune Bio initiated with a Buy at Roth Capital
08/21/19
Fly Intel: Top five analyst initiations
VNDA Vanda Pharmaceuticals
$11.37 /

-0.125 (-1.09%)

06/09/20 Citi
Vanda downgraded to Neutral on FDA dispute at Citi
06/09/20 Citi
Vanda Pharmaceuticals downgraded to Neutral from Buy at Citi
03/16/20
Fly Intel: Top five analyst downgrades
03/16/20 Oppenheimer
Vanda Pharmaceuticals downgraded to Underperform at Oppenheimer on Hetlioz risks
FREQ Frequency Therapeutics
$20.43 /

-2.4 (-10.51%)

16:10 Today Oppenheimer
Frequency Therapeutics initiated with an Outperform at Oppenheimer
05/18/20 JPMorgan
JPMorgan downgrades Frequency Therapeutics on unclear data timelines
05/18/20 JPMorgan
Frequency Therapeutics downgraded to Neutral from Overweight at JPMorgan
10/28/19 JPMorgan
Frequency Therapeutics initiated with an Overweight at JPMorgan
EW Edwards Lifesciences
$67.18 /

-0.67 (-0.99%)

06/05/20 Piper Sandler
Post points to Edwards resuming recruiting for CLASP trial, says Piper Sandler
04/28/20 Wells Fargo
Edwards Lifesciences downgraded on sales growth gap at Wells Fargo
04/28/20 Wells Fargo
Edwards Lifesciences downgraded to Equal Weight from Overweight at Wells Fargo
04/27/20 Barclays
Edwards Lifesciences price target lowered to $155 from $165 at Barclays
BA Boeing
$175.62 /

-2.825 (-1.58%)

07/09/20
Emirates tells Bloomberg Boeing 777X likely to miss 2021 debut
07/08/20 Bernstein
Bernstein downgrades Spirit AeroSystems on slower delivery recovery
06/26/20
Fly Intel: Top five analyst downgrades
06/26/20 RBC Capital
Spirit AeroSystems initiated with an Outperform at RBC Capital
OSMT Osmotica Pharmaceuticals
$7.71 /

-1.06 (-12.09%)

07/10/20 SunTrust
Osmotica Pharmaceuticals price target raised to $11 from $8 at SunTrust
07/09/20 RBC Capital
Osmotica price target raised to $12 from $10 at RBC Capital
03/23/20 Wells Fargo
Wells Fargo downgrades Osmotica to Equal Weight, halves price target to $4
03/23/20 Wells Fargo
Osmotica Pharmaceuticals downgraded to Equal Weight from Overweight at Wells Fargo
ALT Altimmune
$24.88 /

+2.56 (+11.47%)

06/01/20 Roth Capital
Altimmune surprises with differentiated T-COVID study, says Roth Capital
05/06/20 Roth Capital
Novo data 'sets up the runway' for Altimmune, says Roth Capital
04/01/20
Roth Capital biotech analyst to hold an analyst/industry conference call
04/01/20
Roth Capital biotech analyst to hold an analyst/industry conference call
INMB INmune Bio
$8.74 /

+1.72 (+24.50%)

VNDA Vanda Pharmaceuticals
$11.37 /

-0.125 (-1.09%)

FREQ Frequency Therapeutics
$20.43 /

-2.4 (-10.51%)

EW Edwards Lifesciences
$67.18 /

-0.67 (-0.99%)

BA Boeing
$175.62 /

-2.825 (-1.58%)

OSMT Osmotica Pharmaceuticals
$7.71 /

-1.06 (-12.09%)

ALT Altimmune
$24.88 /

+2.56 (+11.47%)

  • 14
    Jul
  • 14
    Jul
  • 09
    Jan
  • 03
    Oct
EW Edwards Lifesciences
$67.18 /

-0.67 (-0.99%)

BA Boeing
$175.62 /

-2.825 (-1.58%)

VNDA Vanda Pharmaceuticals
$11.37 /

-0.125 (-1.09%)

EW Edwards Lifesciences
$67.18 /

-0.67 (-0.99%)

BA Boeing
$175.62 /

-2.825 (-1.58%)

OSMT Osmotica Pharmaceuticals
$7.71 /

-1.06 (-12.09%)

ALT Altimmune
$24.88 /

+2.56 (+11.47%)

FREQ Frequency Therapeutics
$20.43 /

-2.4 (-10.51%)

BA Boeing
$175.62 /

-2.825 (-1.58%)

ALT Altimmune
$24.88 /

+2.56 (+11.47%)

Periodicals
American Airlines to warn employees this week of possible furloughs, CNBC says » 18:50
07/13/20
07/13
18:50
07/13/20
18:50
AAL

American Airlines

$11.63 /

-0.3 (-2.51%)

American Airlines intends…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AAL American Airlines
$11.63 /

-0.3 (-2.51%)

AAL American Airlines
$11.63 /

-0.3 (-2.51%)

07/09/20 Citi
Citi sees expectations for corporate travel rebound all but evaporating
06/17/20
Fly Intel: Top five analyst initiations
06/17/20 Seaport Global
American Airlines initiated with a Buy at Seaport Global
06/17/20 Cowen
American Airlines price target raised to $20 from $15 at Cowen
AAL American Airlines
$11.63 /

-0.3 (-2.51%)

  • 23
    Jun
AAL American Airlines
$11.63 /

-0.3 (-2.51%)

AAL American Airlines
$11.63 /

-0.3 (-2.51%)

AAL American Airlines
$11.63 /

-0.3 (-2.51%)

Periodicals
American Airlines emphases mask rules following Ted Cruz photo, Reuters says » 18:45
07/13/20
07/13
18:45
07/13/20
18:45
AAL

American Airlines

$11.63 /

-0.3 (-2.51%)

American Airlines said it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAL American Airlines
$11.63 /

-0.3 (-2.51%)

AAL American Airlines
$11.63 /

-0.3 (-2.51%)

07/09/20 Citi
Citi sees expectations for corporate travel rebound all but evaporating
06/17/20
Fly Intel: Top five analyst initiations
06/17/20 Seaport Global
American Airlines initiated with a Buy at Seaport Global
06/17/20 Cowen
American Airlines price target raised to $20 from $15 at Cowen
AAL American Airlines
$11.63 /

-0.3 (-2.51%)

  • 23
    Jun
AAL American Airlines
$11.63 /

-0.3 (-2.51%)

AAL American Airlines
$11.63 /

-0.3 (-2.51%)

AAL American Airlines
$11.63 /

-0.3 (-2.51%)

Periodicals
Google offers to not use Fitbit health data for targeted ads, Reuters says » 18:41
07/13/20
07/13
18:41
07/13/20
18:41
GOOG

Alphabet

$1,511.65 /

-30.41 (-1.97%)

, GOOGL

Alphabet Class A

$1,510.81 /

-29.88 (-1.94%)

, FIT

Fitbit

$6.64 /

-0.175 (-2.57%)

Alphabet's (GOOG)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOOG Alphabet
$1,511.65 /

-30.41 (-1.97%)

GOOGL Alphabet Class A
$1,510.81 /

-29.88 (-1.94%)

FIT Fitbit
$6.64 /

-0.175 (-2.57%)

GOOG Alphabet
$1,511.65 /

-30.41 (-1.97%)

06:38 Today Mizuho
Alphabet price target raised to $1,650 from $1,560 at Mizuho
06:24 Today Barclays
Alphabet price target raised to $1,600 from $1,400 at Barclays
07/09/20 Wedbush
Pinterest price target raised to $31 from $26 at Wedbush
07/07/20 BofA
Potential U.S. ban of TikTok could be tailwind to Snap engagement, says BofA
GOOGL Alphabet Class A
$1,510.81 /

-29.88 (-1.94%)

06:38 Today Mizuho
Alphabet price target raised to $1,650 from $1,560 at Mizuho
06:24 Today Barclays
Alphabet price target raised to $1,600 from $1,400 at Barclays
07/09/20 Wedbush
Pinterest price target raised to $31 from $26 at Wedbush
07/07/20 BofA
Potential U.S. ban of TikTok could be tailwind to Snap engagement, says BofA
FIT Fitbit
$6.64 /

-0.175 (-2.57%)

06/19/20 Deutsche Bank
Fitbit acquisition completing remains base case at Deutsche Bank
11/27/19 Deutsche Bank
Second Fitbit suitor should limit downside if deal breaks, says Deutsche Bank
11/06/19 DA Davidson
Sonos rallies after DA Davidson calls 'natural acquisition target' for Apple
11/04/19 DA Davidson
Fitbit downgraded to Neutral from Buy at DA Davidson
GOOG Alphabet
$1,511.65 /

-30.41 (-1.97%)

GOOGL Alphabet Class A
$1,510.81 /

-29.88 (-1.94%)

FIT Fitbit
$6.64 /

-0.175 (-2.57%)

GOOG Alphabet
$1,511.65 /

-30.41 (-1.97%)

GOOGL Alphabet Class A
$1,510.81 /

-29.88 (-1.94%)

FIT Fitbit
$6.64 /

-0.175 (-2.57%)

GOOG Alphabet
$1,511.65 /

-30.41 (-1.97%)

GOOGL Alphabet Class A
$1,510.81 /

-29.88 (-1.94%)

FIT Fitbit
$6.64 /

-0.175 (-2.57%)

GOOG Alphabet
$1,511.65 /

-30.41 (-1.97%)

GOOGL Alphabet Class A
$1,510.81 /

-29.88 (-1.94%)

FIT Fitbit
$6.64 /

-0.175 (-2.57%)

GOOG Alphabet
$1,511.65 /

-30.41 (-1.97%)

GOOGL Alphabet Class A
$1,510.81 /

-29.88 (-1.94%)

Upgrade
SKF AB double-upgraded to Buy from Sell at Goldman Sachs » 18:40
07/13/20
07/13
18:40
07/13/20
18:40
SKFRY

SKF AB

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SKFRY SKF AB
$0.00 /

+ (+0.00%)

07/08/20 JPMorgan
SKF AB price target raised to SEK 165 from SEK 160 at JPMorgan
06/26/20 SEB Equities
SKF AB upgraded to Buy from Hold at SEB Equities
06/12/20 Morgan Stanley
SKF AB price target raised to SEK 180 from SEK 130 at Morgan Stanley
06/03/20 Berenberg
SKF AB price target raised to SEK 200 from SEK 190 at Berenberg
Periodicals
White House to soon end audit deal over Chinese listings in U.S., Reuters says » 18:38
07/13/20
07/13
18:38
07/13/20
18:38
SPX

S&P 500

$0.00 /

+ (+0.00%)

, SPY

SPDR S&P 500 ETF Trust

$314.80 /

-2.81 (-0.88%)

, BABA

Alibaba

$251.71 /

-9.27 (-3.55%)

, JD

JD.com

$62.27 /

-3.33 (-5.08%)

, BIDU

Baidu

$127.96 /

-4.42 (-3.34%)

The White House intends…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$314.80 /

-2.81 (-0.88%)

BABA Alibaba
$251.71 /

-9.27 (-3.55%)

JD JD.com
$62.27 /

-3.33 (-5.08%)

BIDU Baidu
$127.96 /

-4.42 (-3.34%)

SPX S&P 500
$0.00 /

+ (+0.00%)

06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
SPY SPDR S&P 500 ETF Trust
$314.80 /

-2.81 (-0.88%)

06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
BABA Alibaba
$251.71 /

-9.27 (-3.55%)

07/09/20
Fly Intel: Top five analyst initiations
07/09/20 Needham
Alibaba initiated with a Buy at Needham
06/19/20 Barclays
Alibaba price target raised to $270 from $260 at Barclays
06/19/20 Morgan Stanley
6.18 promotion in China released pent-up buying demand, says Morgan Stanley
JD JD.com
$62.27 /

-3.33 (-5.08%)

06/30/20 Mizuho
JD.com price target raised to $75 from $62 at Mizuho
06/19/20 Barclays
JD.com price target raised to $65 from $59 at Barclays
06/19/20 Morgan Stanley
6.18 promotion in China released pent-up buying demand, says Morgan Stanley
06/18/20 Goldman Sachs
JD.com price target raised to $71 from $59 at Goldman Sachs
BIDU Baidu
$127.96 /

-4.42 (-3.34%)

07/02/20 Loop Capital
iQIYI price target raised to $23 from $20 at Loop Capital
06/15/20 Mizuho
Baidu valuation 'compelling' on overstated concerns, says Mizuho
05/20/20 KeyBanc
Baidu price target raised to $145 from $136 at KeyBanc
05/20/20 HSBC
Baidu price target raised to $132 from $120 at HSBC
SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$314.80 /

-2.81 (-0.88%)

BABA Alibaba
$251.71 /

-9.27 (-3.55%)

JD JD.com
$62.27 /

-3.33 (-5.08%)

BIDU Baidu
$127.96 /

-4.42 (-3.34%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$314.80 /

-2.81 (-0.88%)

BABA Alibaba
$251.71 /

-9.27 (-3.55%)

JD JD.com
$62.27 /

-3.33 (-5.08%)

BIDU Baidu
$127.96 /

-4.42 (-3.34%)

BABA Alibaba
$251.71 /

-9.27 (-3.55%)

JD JD.com
$62.27 /

-3.33 (-5.08%)

BIDU Baidu
$127.96 /

-4.42 (-3.34%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$314.80 /

-2.81 (-0.88%)

BABA Alibaba
$251.71 /

-9.27 (-3.55%)

JD JD.com
$62.27 /

-3.33 (-5.08%)

BIDU Baidu
$127.96 /

-4.42 (-3.34%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$314.80 /

-2.81 (-0.88%)

Syndicate
nCino 8.06M share IPO priced at $31.00 » 18:13
07/13/20
07/13
18:13
07/13/20
18:13
NCNO

nCino

$0.00 /

+ (+0.00%)

The deal size was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 14
    Jul
NCNO nCino
$0.00 /

+ (+0.00%)

Hot Stocks
Galera Therapeutics completes enrollment of ph1b/2a clinical trial of GC4419 » 17:47
07/13/20
07/13
17:47
07/13/20
17:47
GRTX

Galera Therapeutics

$7.35 /

+0.22 (+3.09%)

Galera Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GRTX Galera Therapeutics
$7.35 /

+0.22 (+3.09%)

GRTX Galera Therapeutics
$7.35 /

+0.22 (+3.09%)

12/02/19 BTIG
Galera Therapeutics initiated with a Buy at BTIG
12/02/19 Credit Suisse
Galera Therapeutics initiated with a Neutral at Credit Suisse
12/02/19 Citi
Galera Therapeutics initiated with a Buy at Citi
12/02/19 BofA/Merrill
Galera Therapeutics initiated with a Buy at BofA/Merrill
GRTX Galera Therapeutics
$7.35 /

+0.22 (+3.09%)

  • 07
    Nov
Conference/Events
Goldman Sachs Global FX analyst to hold analyst/industry conference call » 17:38
07/13/20
07/13
17:38
07/13/20
17:38

Co-Head of Global FX,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Periodicals
Ford to unveil new Bronco on Monday night, WSJ reports » 17:38
07/13/20
07/13
17:38
07/13/20
17:38
F

Ford

$6.07 /

-0.025 (-0.41%)

, FCAU

Fiat Chrysler

$10.07 /

-0.045 (-0.45%)

For the first time in 24…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
F Ford
$6.07 /

-0.025 (-0.41%)

FCAU Fiat Chrysler
$10.07 /

-0.045 (-0.45%)

F Ford
$6.07 /

-0.025 (-0.41%)

06/25/20 Morgan Stanley
Talks with Ford dealer highlight inventory risk, says Morgan Stanley
06/24/20 Morgan Stanley
GM electric vehicle business could be worth $100B, says Morgan Stanley
06/19/20 JPMorgan
Ford price target raised to $7 from $6 at JPMorgan
06/18/20 Jefferies
Jefferies raises price targets for Ford, GM and FCA on balance sheet de-risking
FCAU Fiat Chrysler
$10.07 /

-0.045 (-0.45%)

06/30/20 UBS
Fiat Chrysler price target raised to EUR 9 from EUR 6 at UBS
06/25/20 Morgan Stanley
Talks with Ford dealer highlight inventory risk, says Morgan Stanley
06/22/20 Redburn
Fiat Chrysler upgraded to Buy from Neutral at Redburn
06/18/20 Jefferies
Jefferies raises price targets for Ford, GM and FCA on balance sheet de-risking
F Ford
$6.07 /

-0.025 (-0.41%)

FCAU Fiat Chrysler
$10.07 /

-0.045 (-0.45%)

F Ford
$6.07 /

-0.025 (-0.41%)

FCAU Fiat Chrysler
$10.07 /

-0.045 (-0.45%)

F Ford
$6.07 /

-0.025 (-0.41%)

FCAU Fiat Chrysler
$10.07 /

-0.045 (-0.45%)

F Ford
$6.07 /

-0.025 (-0.41%)

FCAU Fiat Chrysler
$10.07 /

-0.045 (-0.45%)

Conference/Events
Goldman Sachs semiconductors analyst to hold an analyst/industry conference call » 17:33
07/13/20
07/13
17:33
07/13/20
17:33

US Semi Analyst Hari and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Syndicate
Hycroft files to sell 60.9M shares of common stock, 13.5M warrants for holders  17:32
07/13/20
07/13
17:32
07/13/20
17:32
HYMC

Hycroft Mining

$11.05 /

+0.36 (+3.37%)

 
Syndicate
Entera Bio files $100M mixed securities shelf  17:29
07/13/20
07/13
17:29
07/13/20
17:29
ENTX

Entera Bio

$1.84 /

+0.04 (+2.22%)

 
ShowHide Related Items >><<
ENTX Entera Bio
$1.84 /

+0.04 (+2.22%)

Recommendations
Roth Capital positive on Turning Point Therapeutics appointment of Partridge » 17:28
07/13/20
07/13
17:28
07/13/20
17:28
TPTX

Turning Point Therapeutics

$60.02 /

-0.5 (-0.83%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TPTX Turning Point Therapeutics
$60.02 /

-0.5 (-0.83%)

TPTX Turning Point Therapeutics
$60.02 /

-0.5 (-0.83%)

07/10/20
Fly Intel: Top five analyst initiations
07/09/20 Oppenheimer
Oppenheimer starts precision oncology 'upstart' Turning Point at Outperform
07/09/20 Roth Capital
Turning Point agreement with Zai Lab favorable, says Roth Capital
07/09/20 Oppenheimer
Turning Point Therapeutics initiated with an Outperform at Oppenheimer
TPTX Turning Point Therapeutics
$60.02 /

-0.5 (-0.83%)

  • 19
    May
  • 06
    Sep
Hot Stocks
Mohawk sinks 10% to $68.64 after announcing Class Action lawsuit  17:26
07/13/20
07/13
17:26
07/13/20
17:26
MHK

Mohawk

$76.59 /

+6.06 (+8.59%)

 
ShowHide Related Items >><<
MHK Mohawk
$76.59 /

+6.06 (+8.59%)

MHK Mohawk
$76.59 /

+6.06 (+8.59%)

07/10/20 Jefferies
Mohawk could see short-lived relief rally after flooring data, says Jefferies
07/09/20 Stifel
Stifel says 'difficult if not impossible to opine' on Mohawk allegations
07/09/20 JPMorgan
Allegations in lawsuit to create overhang on Mohawk shares, says JPMorgan
07/09/20 SunTrust
Mohawk quiet period hinders lawsuit response, says SunTrust
MHK Mohawk
$76.59 /

+6.06 (+8.59%)

MHK Mohawk
$76.59 /

+6.06 (+8.59%)

MHK Mohawk
$76.59 /

+6.06 (+8.59%)

MHK Mohawk
$76.59 /

+6.06 (+8.59%)

Hot Stocks
Triumph Group names Tom Blakely group CTO » 17:26
07/13/20
07/13
17:26
07/13/20
17:26
TGI

Triumph Group

$8.09 /

-0.165 (-2.00%)

Triumph Group announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TGI Triumph Group
$8.09 /

-0.165 (-2.00%)

TGI Triumph Group
$8.09 /

-0.165 (-2.00%)

03/20/20 BofA
BofA double downgrades Triumph, slashes price target amid COVID-19 impact
03/20/20 BofA
Triumph Group downgraded to Underperform from Buy at BofA
03/11/20 Goldman Sachs
Goldman cuts targets across Aerospace coverage for COVID-19 impact
08/23/19
Fly Intel: Top five analyst downgrades
TGI Triumph Group
$8.09 /

-0.165 (-2.00%)

TGI Triumph Group
$8.09 /

-0.165 (-2.00%)

Conference/Events
Susquehanna technology analyst to hold analyst/industry conference call » 17:25
07/13/20
07/13
17:25
07/13/20
17:25
AMD

AMD

$53.58 /

-2.31 (-4.13%)

Technology Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMD AMD
$53.58 /

-2.31 (-4.13%)

AMD AMD
$53.58 /

-2.31 (-4.13%)

06/19/20 Jefferies
AMD still taking share in CPU-only cloud instances, says Jefferies
06/15/20 Piper Sandler
AMD well positioned for continued market share gains, says Piper Sandler
06/15/20 Nomura Instinet
AMD on pace for 20%-30% sales growth in 2020, says Nomura Instinet
06/12/20 Rosenblatt
Rosenblatt says Jim Keller's departure from Intel a 'big deal'
AMD AMD
$53.58 /

-2.31 (-4.13%)

AMD AMD
$53.58 /

-2.31 (-4.13%)

AMD AMD
$53.58 /

-2.31 (-4.13%)

AMD AMD
$53.58 /

-2.31 (-4.13%)

Hot Stocks
Mohawk says Class Action lawsuit filed against company » 17:24
07/13/20
07/13
17:24
07/13/20
17:24
MHK

Mohawk

$76.59 /

+6.06 (+8.59%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MHK Mohawk
$76.59 /

+6.06 (+8.59%)

MHK Mohawk
$76.59 /

+6.06 (+8.59%)

07/10/20 Jefferies
Mohawk could see short-lived relief rally after flooring data, says Jefferies
07/09/20 Stifel
Stifel says 'difficult if not impossible to opine' on Mohawk allegations
07/09/20 JPMorgan
Allegations in lawsuit to create overhang on Mohawk shares, says JPMorgan
07/09/20 SunTrust
Mohawk quiet period hinders lawsuit response, says SunTrust
MHK Mohawk
$76.59 /

+6.06 (+8.59%)

MHK Mohawk
$76.59 /

+6.06 (+8.59%)

MHK Mohawk
$76.59 /

+6.06 (+8.59%)

MHK Mohawk
$76.59 /

+6.06 (+8.59%)

Hot Stocks
Invitae CMO sells 29.8K shares of common stock » 17:24
07/13/20
07/13
17:24
07/13/20
17:24
NVTA

Invitae

$32.78 /

-0.72 (-2.15%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVTA Invitae
$32.78 /

-0.72 (-2.15%)

NVTA Invitae
$32.78 /

-0.72 (-2.15%)

07/01/20 Benchmark
Benchmark says Invitae 'ahead of itself,' downgrades to Hold after run-up
07/01/20 Benchmark
Invitae downgraded to Hold from Buy at Benchmark
06/26/20 Cowen
Invitae price target raised to $35 from $18 at Cowen
06/22/20 Piper Sandler
Invitae deal for ArcherDx presents little threat to Natera, says Piper Sandler
NVTA Invitae
$32.78 /

-0.72 (-2.15%)

  • 02
    Apr
NVTA Invitae
$32.78 /

-0.72 (-2.15%)

NVTA Invitae
$32.78 /

-0.72 (-2.15%)

Hot Stocks
Boeing awarded $22.89B Air Force contract for F-15EX system » 17:21
07/13/20
07/13
17:21
07/13/20
17:21
BA

Boeing

$175.62 /

-2.825 (-1.58%)

Boeing has been awarded a…

Boeing has been awarded a $22.89B indefinite-delivery/indefinite-quantity contract. The first delivery order has been awarded as an undefinitized contract action with a total not-to-exceed value, including options, of $1.19B. It is a cost-plus-fixed-fee, cost-plus-incentive-fee, fixed-price-incentive-fee, firm-fixed-price effort for the F-15EX system. This delivery order provides for design, development, integration, manufacturing, test, verification, certification, delivery, sustainment and modification of F-15EX aircraft, as well as spares, support equipment, training materials, technical data and technical support. Work will be performed in St. Louis, Missouri and at Eglin Air Force Base, Florida, and is expected to be completed December 31, 2023. This award is the result of a sole-source acquisition. FY20 research, development, test and evaluation funds in the amount of $248.22M and FY20 aircraft procurement funds in the amount of $53M are being obligated at the time of award. Air Force Life Cycle Management Center is the contracting activity.

ShowHide Related Items >><<
BA Boeing
$175.62 /

-2.825 (-1.58%)

BA Boeing
$175.62 /

-2.825 (-1.58%)

07/09/20
Emirates tells Bloomberg Boeing 777X likely to miss 2021 debut
07/08/20 Bernstein
Bernstein downgrades Spirit AeroSystems on slower delivery recovery
06/26/20
Fly Intel: Top five analyst downgrades
06/26/20 RBC Capital
Spirit AeroSystems initiated with an Outperform at RBC Capital
BA Boeing
$175.62 /

-2.825 (-1.58%)

BA Boeing
$175.62 /

-2.825 (-1.58%)

BA Boeing
$175.62 /

-2.825 (-1.58%)

BA Boeing
$175.62 /

-2.825 (-1.58%)

Conference/Events
Susquehanna technology analyst to hold analyst/industry conference call » 17:20
07/13/20
07/13
17:20
07/13/20
17:20

Technology Analyst Patil…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Syndicate
Enochian Biosciences files to sell $50M of common stock  17:15
07/13/20
07/13
17:15
07/13/20
17:15
ENOB

Enochian Biosciences

$3.70 /

-0.19 (-4.88%)

 
ShowHide Related Items >><<
ENOB Enochian Biosciences
$3.70 /

-0.19 (-4.88%)

Conference/Events
UBS consumer goods analyst to hold an analyst/industry conference call » 17:15
07/13/20
07/13
17:15
07/13/20
17:15

Consumer Goods Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Medley Capital announce one-for-twenty reverse stock split » 17:13
07/13/20
07/13
17:13
07/13/20
17:13
MCC

Medley Capital

$0.66 /

-0.014 (-2.07%)

Medley Capital announced…

Medley Capital announced that, following the company's annual meeting of stockholders, the company's board of directors determined that it is in the best interests of the company and its stockholders to effect a reverse stock split of its common stock, par value $0.001, of 1-20 and reduce the number of authorized shares of common stock by the reverse stock split ratio. Accordingly, on July 13, the company filed a certificate of amendment to the certificate of incorporation with the Secretary of State of the State of Delaware to effect the reverse stock split and the authorized share reduction, which will be effective on July 24. Pursuant to the certificate of amendment, effective as of July 24, each 20 shares of common stock issued and outstanding, immediately prior to the effective time, will automatically and without any action on the part of the respective holders thereof, be combined and converted into one share of common stock. In connection with the reverse stock split, the certificate of amendment provides that the number of authorized shares of common stock will be reduced proportionately from 100M to 5M shares of common stock. No fractional shares will be issued as a result of the reverse stock split. Instead, any stockholder who would have been entitled to receive a fractional share as a result of the reverse stock split will receive cash payments in lieu of such fractional shares. The common stock will begin trading on a split-adjusted basis on the NYSE at the market open on July 27. As previously disclosed, the reverse stock split is intended to bring the company into compliance with the $1.00 minimum average closing share price requirement for continued listing on the NYSE. The company will regain compliance with the minimum share price requirement if the price per share of common stock promptly exceeds $1.00 per share and remains above that level for at least the following 30 trading days.

ShowHide Related Items >><<
MCC Medley Capital
$0.66 /

-0.014 (-2.07%)

MCC Medley Capital
$0.66 /

-0.014 (-2.07%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.